{"id":8848,"date":"2026-09-09T17:45:10","date_gmt":"2026-09-09T17:45:10","guid":{"rendered":"https:\/\/intelekbusinessvaluations.com\/en-au\/?page_id=8848"},"modified":"2026-09-09T18:41:23","modified_gmt":"2026-09-09T18:41:23","slug":"employee-share-schemes-incentive-equity","status":"publish","type":"page","link":"https:\/\/intelekbusinessvaluations.com\/en-au\/employee-share-schemes-incentive-equity\/","title":{"rendered":"Employee Share Schemes & Incentive Equity Services"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

Division 83A ITAA 1997 & AASB 2 Share-based Payment<\/h4>

Why Employee Share Scheme Valuations Matter<\/h3>

When you grant shares, options, performance rights, or units to employees, you create two separate valuation obligations that most companies discover too late are not the same thing. Division 83A of the ITAA 1997 governs when and how much the employee is taxed, and the market value of the interest at the relevant time determines that liability. AASB 2 Share-based Payment governs your accounting expense, measured at grant-date fair value and recognised over the vesting period. Different standards, different measurement dates, different valuation bases, and different numbers.<\/p>

Getting either wrong carries real consequences. An understated market value under Division 83A exposes the employee to ATO amendment and shortfall penalties, and the company to reporting failures under its ESS reporting obligations. Missing the conditions for the start-up concession \u2014 a genuine risk given how prescriptive the eligibility criteria are \u2014 means an employee who expected deferred CGT treatment on a discounted grant instead faces an immediate income tax liability on value they cannot realise. On the accounting side, understating grant-date fair value or misapplying the treatment of vesting conditions distorts reported earnings, and for companies raising capital or preparing for a transaction, an AASB 2 error discovered in due diligence is both expensive and embarrassing. Options and performance rights require option-pricing models; a simple intrinsic-value calculation will not survive audit.<\/p>

Working with an accredited valuation specialist who understands both the Division 83A market value rules and AASB 2’s measurement requirements is the single most important step to protect the company and the employees it is trying to reward.<\/p>

InteleK’s team of accredited valuation specialists delivers valuations for the full range of incentive equity \u2014 ordinary and preference shares, options, performance rights, loan-funded share plans, and phantom or cash-settled awards \u2014 supporting both ATO market value requirements under Division 83A and audit-ready grant-date fair values under AASB 2.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

Book a Free Consultation Call<\/h3>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

One of InteleK\u00b4s accredited appraisers is available to listen to your story and answer any questions you may have.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t
\r\n \r\n
\r\n \"Andrew\r\n \r\n Andrew Mackson, CFA, ABV\r\n Book Appointment\r\n <\/span>\r\n <\/span>\r\n <\/div>\r\n <\/a>\r\n<\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Purchase\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

Division 83A \u2014 The Tax Framework<\/h3>

Division 83A applies where an employee acquires an ESS interest \u2014 a beneficial interest in a share, or a right to acquire a beneficial interest in a share \u2014 at a discount, in relation to their employment.<\/p>

Upfront Taxation<\/h4>

The default position is that the discount is included in the employee’s assessable income in the year the interest is acquired. The discount is the market value of the interest at acquisition, less any consideration the employee paid.<\/p>

A limited upfront concession<\/strong> allows up to $1,000 of the discount to be exempt where the employee’s adjusted taxable income does not exceed $180,000, the scheme meets minimum holding and non-forfeiture conditions, and the scheme is offered broadly to at least 75% of Australian-resident permanent employees with three or more years of service.<\/p>

Deferred Taxation<\/h4>

Where the conditions in Subdivision 83A-C are met, taxation is deferred to the ESS deferred taxing point<\/strong> \u2014 broadly the earliest of when there is no real risk of forfeiture and no genuine disposal restriction, when employment ends, or 15 years from acquisition. The market value at that deferred taxing point becomes the assessable discount, which means a valuation is required at that date, not at grant.<\/p>

Deferral is available where the interest is subject to a real risk of forfeiture, or where the scheme is a qualifying salary-sacrifice arrangement, or for rights where the scheme genuinely restricts disposal. The 30-day rule applies: where the interest is disposed of within 30 days of the deferred taxing point, that disposal date becomes the taxing point instead.<\/p>

The Start-Up Concession<\/h4>

Subdivision 83A-33 provides the most valuable concession available, but eligibility is strictly conditional. The company must:<\/p>

  • Not be listed on any approved stock exchange<\/li>
  • Have been incorporated for less than 10 years<\/li>
  • Have aggregated turnover of $50 million or less in the prior income year<\/li>
  • Be an Australian-resident company<\/li><\/ul>

    And the interest must satisfy further conditions, including a minimum three-year holding period, employment-based eligibility, and \u2014 critically \u2014 a discount limit<\/strong>: shares must be issued at no more than a 15% discount to market value, and options must have an exercise price at or above the market value of the underlying share at grant.<\/p>

    Where the concession applies, no amount is assessable at grant. The interest instead falls into the CGT regime with a cost base equal to what the employee paid, and the CGT discount is available on eventual disposal subject to the holding period.<\/p>

    The discount limit is where a market valuation becomes unavoidable. Establishing that shares were issued within 15% of market value, or that an option’s exercise price was at or above market value, requires a supportable valuation at grant date. Get that valuation wrong and the entire concession fails \u2014 converting what the employee understood to be a capital gain into assessable income.<\/p>

    Determining Market Value<\/h4>

    For unlisted companies, market value is determined under general principles derived from Spencer v Commonwealth<\/em> and the ATO’s market valuation guidelines: the price agreed between a willing but not anxious buyer and seller, both fully informed, in an arm’s length transaction.<\/p>

    The ATO provides safe harbour valuation methods<\/strong> for start-up ESS interests in the Income Tax Assessment (1997 Act) Regulations, including a net tangible assets method and, for options, a table-based approach that values the option by reference to the market value of the underlying share, the exercise price and the time to expiry. These methods offer certainty but frequently produce values that bear little relationship to what the equity is actually worth \u2014 sometimes to the company’s advantage, sometimes not.<\/p>

    Where the safe harbour is unsuitable or unavailable, a proper valuation is required. For a company that has recently raised capital, the round price is the natural starting point, but it is not automatically the market value of the ordinary shares being issued to employees: preference shares carrying liquidation preferences, dividend rights and anti-dilution protection are worth more than the ordinary shares employees receive, and treating the two as equivalent overstates the employee’s taxable discount and inflates the option exercise price required for start-up concession eligibility.<\/p>

    ESS Reporting Obligations<\/h4>

    Employers must provide an ESS statement to each affected employee by 14 July following the income year, and lodge an ESS annual report with the ATO by 14 August. Both require the market value figures the valuation produces. Late or inaccurate reporting attracts administrative penalties independent of any underlying tax shortfall.<\/p>

    AASB 2 \u2014 The Accounting Framework<\/h3>

    AASB 2 requires an expense to be recognised for the goods or services received in a share-based payment transaction, measured by reference to the fair value of the award. For employee awards, that fair value is measured at grant date<\/strong> and is not subsequently revised for changes in the share price.<\/p>

    Equity-Settled vs Cash-Settled<\/h4>

    Equity-settled awards<\/strong> \u2014 Shares, options and performance rights settled in the company’s own equity. Measured at grant-date fair value and recognised as an expense with a corresponding credit to equity over the vesting period. The grant-date measurement is locked in: a subsequent fall in the share price does not reduce the expense.<\/p>

    Cash-settled awards<\/strong> \u2014 Phantom shares, share appreciation rights, and awards the company is obliged to settle in cash. Measured at fair value at each reporting date until settlement, with changes recognised in profit or loss. This creates ongoing earnings volatility that equity-settled awards do not.<\/p>

    The distinction turns on the substance of the settlement obligation, not the label on the plan. Awards with a cash-settlement election, or a past practice of settling in cash, may be cash-settled in substance regardless of the plan rules.<\/p>

    Treatment of Vesting Conditions<\/h4>

    This is where AASB 2 most often goes wrong, because the standard treats conditions asymmetrically:<\/p>

    Service conditions<\/strong> \u2014 Continued employment for a period. Not included in grant-date fair value. Instead, the expense is recognised over the vesting period based on the number of awards expected to vest, with the estimate trued up each period to reflect actual and expected forfeitures. If an employee leaves before vesting, the cumulative expense for their award is reversed.<\/p>

    Non-market performance conditions<\/strong> \u2014 EBITDA targets, revenue targets, regulatory approvals, individual KPIs. Also excluded from grant-date fair value and handled through the vesting estimate. If the condition ultimately is not met, the expense is reversed entirely.<\/p>

    Market conditions<\/strong> \u2014 Total shareholder return hurdles, share price targets, relative TSR against a peer index. These are<\/strong> included in the grant-date fair value, typically via Monte Carlo simulation. Because the condition is built into the measurement, the expense is not<\/strong> reversed if the condition is never met \u2014 the company recognises the full expense for an award that delivered nothing. This surprises boards routinely and is worth raising before a plan is designed rather than after.<\/p>

    Non-vesting conditions<\/strong> \u2014 Conditions that are neither service nor performance conditions, such as a requirement to continue making salary-sacrifice contributions. Included in grant-date fair value, with no reversal.<\/p>

    Valuation Models<\/h4>

    Ordinary shares granted outright<\/strong> \u2014 Fair value is the market value of the share at grant date, adjusted for any restrictions that a market participant would price. For unlisted companies this requires an equity valuation and, where the capital structure includes preference classes, an allocation across classes.<\/p>

    Options and performance rights<\/strong> \u2014 Require an option-pricing model. Black-Scholes is acceptable for simple awards with a fixed exercise price and no early-exercise behaviour. A binomial or trinomial lattice is preferable where early exercise, staged vesting or variable inputs are relevant. Monte Carlo simulation is required for market conditions, TSR hurdles, and path-dependent payoffs.<\/p>

    Key inputs each require support: the underlying share value, exercise price, expected term (not simply the contractual term), expected volatility, risk-free rate, and expected dividend yield.<\/p>

    Expected volatility<\/strong> is the input auditors question most for unlisted companies, since there is no share price history. The accepted approach is a peer group of listed comparables, matched on industry, size and leverage, with the observation period aligned to the expected term of the award. The peer selection and the resulting figure both need documenting.<\/p>

    Loan-funded share plans<\/strong> \u2014 Where employees acquire shares funded by a limited-recourse company loan, the arrangement is economically an option and must be valued as one under AASB 2, regardless of the fact that legal title to shares has passed. The limited-recourse feature is the option characteristic.<\/p>

    Modifications, Cancellations and Repricing<\/h4>

    Where an award is modified, AASB 2 requires the original grant-date expense to continue being recognised, plus any incremental fair value created by the modification measured at the modification date. Repricing options downward after a share price fall creates incremental fair value and additional expense \u2014 it does not reduce the original charge.<\/p>

    A cancellation is treated as an acceleration of vesting, with the remaining unrecognised expense recognised immediately. Where a cancelled award is replaced, the replacement may be accounted for as a modification rather than a new grant, which materially changes the expense profile.<\/p>

    Group and Parent-Subsidiary Arrangements<\/h4>

    Where a parent grants awards over its own equity to employees of a subsidiary, both entities have accounting consequences: the subsidiary recognises an expense with a corresponding capital contribution from the parent, and the parent recognises an increase in its investment in the subsidiary. This is routinely missed in subsidiary standalone financial statements.<\/p>

    Where the Two Frameworks Diverge<\/h3>

    The most common and costly misunderstanding in this area is the assumption that one valuation serves both purposes.<\/p>

    \u00a0<\/th>Division 83A<\/th>AASB 2<\/th><\/tr><\/thead>
    Purpose<\/strong><\/td>Employee’s taxable discount<\/td>Company’s accounting expense<\/td><\/tr>
    Basis<\/strong><\/td>Market value<\/td>Fair value<\/td><\/tr>
    Measurement date<\/strong><\/td>Acquisition, or ESS deferred taxing point<\/td>Grant date only<\/td><\/tr>
    Options<\/strong><\/td>Often ATO safe harbour tables<\/td>Option-pricing model required<\/td><\/tr>
    Market conditions<\/strong><\/td>Reflected in market value<\/td>Built into grant-date fair value, no reversal<\/td><\/tr>
    Service conditions<\/strong><\/td>Relevant to deferral and taxing point<\/td>Excluded from fair value, handled via vesting estimate<\/td><\/tr>
    Revision<\/strong><\/td>Fresh valuation at deferred taxing point<\/td>Never revised for share price<\/td><\/tr><\/tbody><\/table><\/div>

    A single number used for both will be wrong for at least one of them. Where the divergence is material, both figures need to be documented and reconciled \u2014 particularly if the company is heading toward an audit, a capital raise, or a transaction where both sets of numbers will be examined.<\/p>

    Deductibility and Payroll Tax<\/h3>

    The employer’s income tax deduction for share-based remuneration does not follow the AASB 2 accounting expense. Deductions for providing ESS interests are generally denied under s 26-70 and the specific ESS provisions, with limited exceptions \u2014 most notably where the company incurs actual costs in acquiring shares on-market through an employee share trust. The AASB 2 expense is a permanent difference in most cases, and the deferred tax consequences under AASB 112 need to be assessed on the specific structure.<\/p>

    State payroll tax generally applies to the grant of shares and options as taxable wages, with each state and territory setting its own rules on the timing and the value on which liability is calculated. The relevant value date differs between jurisdictions and from both the Division 83A and AASB 2 dates \u2014 a third valuation date in some cases.<\/p>

    InteleK’s Approach to Employee Share Scheme Valuations<\/h3>

    Our accredited valuers bring both Division 83A and AASB 2 experience to every incentive equity engagement. Here’s what sets our process apart:<\/p>

    Both Frameworks Addressed, Separately<\/strong> \u2014 We deliver the Division 83A market value and the AASB 2 grant-date fair value as distinct conclusions, with the basis for each documented and the divergence explained. One number used for both purposes is the single most common error we see.<\/p>

    Start-Up Concession Support<\/strong> \u2014 Where the concession is being relied on, we provide the valuation evidence establishing that shares were issued within the 15% discount limit or that option exercise prices were at or above market value at grant. We will also tell you plainly where we think the concession is at risk, before the grants are made.<\/p>

    Capital Structure Allocation<\/strong> \u2014 Where a company has raised preference capital, we allocate value across share classes rather than applying the round price to ordinary shares granted to employees. Treating preference and ordinary shares as equivalent overstates the employee’s taxable discount and can defeat start-up concession eligibility.<\/p>

    Correct Model for the Award<\/strong> \u2014 Black-Scholes where it suffices, lattice models where early exercise or staged vesting matters, and Monte Carlo simulation for TSR hurdles and path-dependent conditions. Every input sourced, with peer-group volatility derivation documented for audit.<\/p>

    Vesting Condition Analysis Before Plan Design<\/strong> \u2014 Where we are engaged before grants are made, we flag the AASB 2 consequences of the proposed conditions \u2014 in particular that a market condition produces an unreversible expense even if the hurdle is never met. Boards are frequently unaware of this until the first reporting period.<\/p>

    Modification and Repricing Modelling<\/strong> \u2014 Incremental fair value calculated at the modification date, with the resulting expense profile set out so the earnings impact is known before the decision is made rather than after.<\/p>

    Audit-Ready Documentation<\/strong> \u2014 Every judgement sourced and explained, in a report structured for the way auditors test share-based payment under ASA 540 Auditing Accounting Estimates.<\/p>

    Collaboration With Your Advisers<\/strong> \u2014 We work alongside your tax adviser, legal counsel, auditor and remuneration committee. Plan design, tax treatment and accounting expense interact, and a valuation delivered in isolation from the other three tends to need redoing.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t
    \r\n